loadpatents
name:-0.0063159465789795
name:-0.0092308521270752
name:-0.00039386749267578
FAB PHARMA SAS Patent Filings

FAB PHARMA SAS

Patent Applications and Registrations

Patent applications and USPTO patent grants for FAB PHARMA SAS.The latest application filed is for "novel drug formulation".

Company Profile
0.10.9
  • FAB PHARMA SAS - Paris FR
  • FAB PHARMA S.A.S. - Paris FR
  • FAB PHARMA S.A.S - Paris N/A FR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Novel Drug Formulation
App 20160206577 - GERUSZ; Vincent ;   et al.
2016-07-21
Heterocyclic acrylamides and their use as pharmaceuticals
Grant 9,321,769 - Gerusz , et al. April 26, 2
2016-04-26
Hydroxyphenyl derivatives and biological applications thereof
Grant 9,309,179 - Denis , et al. April 12, 2
2016-04-12
Antibacterial hydroxyphenyl compound
Grant 9,272,985 - Gerusz , et al. March 1, 2
2016-03-01
Novel Heterocyclic Acrylamides And Their Use As Pharmaceuticals
App 20150232466 - GERUSZ; Vincent ;   et al.
2015-08-20
Heterocyclic acrylamides and their use as pharmaceuticals
Grant 9,051,321 - Gerusz , et al. June 9, 2
2015-06-09
Novel Drug Combination
App 20150065416 - Mouze; Coralie ;   et al.
2015-03-05
Novel Heterocyclic Acrylamides And Their Use As Pharmaceuticals
App 20140357617 - Gerusz; Vincent ;   et al.
2014-12-04
Heterocyclic acrylamides and their use as pharmaceuticals
Grant 8,846,711 - Gerusz , et al. September 30, 2
2014-09-30
Hydroxyphenyl Derivatives And Biological Applications Thereof
App 20140213589 - DENIS; Alexis ;   et al.
2014-07-31
Hydroxyphenyl derivatives and biological applications thereof
Grant 8,722,746 - Denis , et al. May 13, 2
2014-05-13
Acylpiperazinones and their use as pharmaceuticals
Grant 8,623,865 - Gerusz , et al. January 7, 2
2014-01-07
Novel Acylpiperazinones And Their Use As Pharmaceuticals
App 20130137689 - GERUSZ; Vincent ;   et al.
2013-05-30
Acylpiperazinones and their use as pharmaceuticals
Grant 8,383,621 - Gerusz , et al. February 26, 2
2013-02-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed